Tekla Capital Management LLC Eli Lilly & CO Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tekla Capital Management LLC holds 213,352 shares of LLY stock, worth $165 Million. This represents 3.96% of its overall portfolio holdings.

Number of Shares

213,352

Previous 288,917 26.15%

Holding current value

$165 Million

Previous $99.2 Million 0.84%

% of portfolio

3.96%

Previous 3.81%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$350.74 - $468.98 $26.5 Million - $35.4 Million	-75,565 Reduced 26.15%	213,352 $100 Million
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $15.5 Million - $18.1 Million	48,339 Added 20.09%	288,917 $106 Million
Q3 2022 Nov 01, 2022	BUY	$296.48 - $337.87 $19 Million - $21.7 Million	64,146 Added 36.36%	240,578 $77.8 Million
Q2 2022 Jul 29, 2022	SELL	$278.73 - $327.27 $9.87 Million - $11.6 Million	-35,400 Reduced 16.71%	176,432 $57.2 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $4.37 Million - $5.42 Million	-18,600 Reduced 8.07%	211,832 $60.7 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $10.1 Million - $12.6 Million	-45,000 Reduced 16.34%	230,432 $63.7 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $4.18 Million - $5.15 Million	18,871 Added 7.36%	275,432 $63.6 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $6.42 Million - $8.3 Million	-35,553 Reduced 12.17%	256,561 $58.9 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $8.97 Million - $11.6 Million	54,577 Added 22.98%	292,114 $54.6 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $7.81 Million - $10.3 Million	59,900 Added 33.72%	237,537 $40.1 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $4.27 Million - $4.94 Million	-29,200 Reduced 14.12%	177,637 $26.3 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $7.07 Million - $8.51 Million	-51,832 Reduced 20.04%	206,837 $34 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $5.77 Million - $7.14 Million	48,488 Added 23.07%	258,669 $35.9 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $5.69 Million - $7.05 Million	53,223 Added 33.91%	210,181 $27.6 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $10.3 Million - $11.2 Million	-96,241 Reduced 38.01%	156,958 $17.6 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $4.67 Million - $5.45 Million	-42,121 Reduced 14.26%	253,199 $28.1 Million
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $8.78 Million - $10.3 Million	78,878 Added 36.44%	295,320 $38.3 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $14.9 Million - $18.6 Million	-173,666 Reduced 44.52%	216,442 $23.2 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $7.32 Million - $8.41 Million	-96,757 Reduced 19.87%	390,108 $33.3 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $7.7 Million - $9.09 Million	103,766 Added 27.09%	486,865 $37.7 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $409,781 - $439,537	-5,001 Reduced 1.29%	383,099 $32.4 Million
Q3 2017 Nov 13, 2017	SELL	$77.07 - $85.54 $8.09 Million - $8.98 Million	-105,000 Reduced 21.29%	388,100 $33.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	493,100	493,100 $40.6 Million

Others Institutions Holding LLY

# of Institutions

4,012

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $735B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Eli Lilly & CO Transaction History